Provider attributes associated with hormone therapy prescribing frequency

Menopause

Volumn 16, Issue 4, 2009, Pages 810-816

  Spangler, Leslie ^a   Reed, Susan D ^a,b,c   Nekhyludov, Larissa ^d,e   Grothaus, Louis C ^a   Lacroix, Andrea Z ^a,c   Newton, Katherine M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

Hormone therapy; Menopause; Physiciana's practice; Prescriptions

Indexed keywords

ESTROGEN; GESTAGEN;

AGE; ARTICLE; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; GENERAL PRACTITIONER; GEOGRAPHY; HORMONAL THERAPY; HUMAN; INTEGRATED HEALTH CARE SYSTEM; INTERNIST; MEDICAL SPECIALIST; MENOPAUSE; OBSTETRICIAN GYNECOLOGIST; PATIENT COUNSELING; PRESCRIPTION; RISK; SELF REPORT; STATISTICAL ANALYSIS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; ESTROGEN REPLACEMENT THERAPY; FAMILY PRACTICE; FEMALE; GYNECOLOGY; HEALTH PERSONNEL; HUMANS; INTERNAL MEDICINE; MALE; MENOPAUSE; MIDDLE AGED; OBSTETRICS; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS;

EID: 68449088230     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318198e2fd     Document Type: Article

References (28)

1. U.S. Census Bureau. State Interim Population Projections by Age and Sex: 2004-2030. Available at: http://www.census.gov/population/www/projections/ projectionsagesex.html. Accessed July 6, 2007.
2. Williams RE, Kalilani L, DiBenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric 2008;11:32-43.
3. Feldman BM, Voda A, Gronseth E. The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Health 1985;8:261-268.
4. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N EnglJ Med 1991;325:756-762.
5. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
6. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662.
7. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
8. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53.
9. Majumdar SR, Almasi EA, Stafford RS. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA 2004;292:1983-1988.
10. Power ML, Schulkin J, Rossouw JE. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists. Menopause 2007;14:20-28.
11. Connelly MT, Ferrari N, Hagen N, Inui TS. Patient-identified needs for hormone replacement therapy counseling: a qualitative study. Ann Intern Med 1999;131:265-268.
12. Connelly MT, Rusinak D, Livingston W, Raeke L, Inui TS. Patient knowledge about hormone replacement therapy: implications for treatment. Menopause 2000;7:266-272.
13. Kaufert P, Boggs PP, Ettinger B, Woods NF, Utian WH. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey. Menopause 1998;5:197-202.
14. MacDougall LA, Barzilay JI, Heimick CG. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years. J Womens Health Gend Based Med 1999;8:1203-1211.
15. Newton KM, LaCroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. Women's beliefs and decisions about hormone replacement therapy. J Womens Health 1997;6:459-465.
16. Hing E, Brett KM. Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003. Obstet Gynecol 2006;108:33-40.
17. Burg MA, Fraser K, Gui S, et al. Treatment of menopausal symptoms in family medicine settings following the Women's Health Initiative findings. J Am Board Fam Med 2006;19:122-131.
18. Sangi-Haghpeykar H, Poindexter AN 3rd. Physicians' views and practices concerning menopausal hormone therapy. Maturitas 2007;56:30-37.
19. Hartsfield CL, Connelly MT, Newton KM, Andrade SE, Wei F, Buist DS. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response. J Natl Cancer Inst Monogr 2005;35:113-115.
20. Newton KM, LaCroix AZ, Buist DS, Anderson LA, Delaney K. What factors account for hormone replacement therapy prescribing frequency? Maturitas 2001;39:1-10.
21. Fishman PA, Goodman MJ, Hornbrook MC, Meenan RT, Bachman DJ, O'Keeffe Rosetti MC. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care 2003;41:84-99.
22. Rosner B. In: Kugushev A, ed. Fundamentals of Biostatistics. 4th ed. New York: Duxbury Press, 1995:314-317.
23. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947-2958.
24. Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999;130:545-553.
25. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-545.
26. Brett KM, Reuben CA. Prevalence of estrogen or estrogen-progestin hormone therapy use. Obstet Gynecol 2003;102:1240-1249.
27. Williams RS, Christie D, Sistrom C. Assessment of the understanding of the risks and benefits of hormone replacement therapy (HRT) in primary care physicians. Am J Obstet Gynecol 2005;193:551-556; discussion 556-558.
28. Power ML, Baron J, Schulkin J. Factors associated with obstetrician-gynecologists' response to the Women's Health Initiative trial of combined hormone therapy. Med Decis Making 2008;28:411-418.